Related Content
May 12, 2017 — PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania in a trial assessing ...
March 3, 2017 — Biosensors International Group Ltd. announced in February enrollment of the first patient in LEADERS ...
November 7, 2016 – The two-year results from LEADERS FREE, the first randomized clinical trial dedicated to high ...
May 16, 2016 — Cardinal Health announced it has entered into a distribution agreement with Biosensors that enables ...
October 22, 2015 — Results from the LEADERS FREE trial found that a polymer-free drug-coated stent (DCS) was superior to ...
August 28, 2015 — PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania and second in the ...
February 2, 2015 — Biosensors International Group has announced a distribution agreement with Veryan Medical Ltd. for ...
October 28, 2013 — Biosensors International’s expanded product portfolio offers physicians a broader range of treatment ...
June 20, 2013 — Biosensors International Group Ltd. has entered into a licensing agreement with Eurocor GmbH, a group ...
The interventional cardiology market includes, but is not limited to, drug-eluting stents, bare-metal stents ...